secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001193125-23-030275
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences amends bylaws to update stockholder meeting procedures
------------------------------------------------------------------------

- Bylaws revised to require stockholder nominating directors to deliver evidence of Rule 14a-19 compliance at least 5 business days before meeting.
- Changes conform to recent amendments to the Delaware General Corporation Law.
- Amendments also include ministerial and clarifying revisions to align with current Delaware law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523030275/0001193125-23-030275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523030275/d466499d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-030275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer